Health Care

Hims & Hers ZAVA Acquisition Deal Expands Its Market Opportunity By $52 Billion: Analyst

AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point

Newly-Listed Sionna Therapeutics Touts Positive Data From Lung Disease Candidate In Healthy Volunteer Trial

AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point

Newly-Listed Sionna Therapeutics Touts Positive Data From Lung Disease Candidate In Healthy Volunteer Trial

Why Is Sharps Technology Stock Soaring On Wednesday?

What's Behind Cellectar Biosciences' Stock Surge? FDA Update Explained

Why Is Sharps Technology Stock Soaring On Wednesday?

What's Behind Cellectar Biosciences' Stock Surge? FDA Update Explained

Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps

HealthEquity Shares Trade Higher After Better-Than-Expected Q1 Report: Here's Why

Health Care Recent News

Organic Rancher Beef Supplied To Whole Foods Flagged For E.Coli, USDA Urges Shoppers To Take This Action

Whole Foods' Organic Rancher ground beef linked to E. coli outbreak. FSIS issued public health alert and urged consumers to check for recalled product.

Analyst Upgrades Agenus As Zydus Deal Alleviates Cash Overhang

Zydus acquires two Agenus biologics facilities in California for $75 million, expanding U.S. CDMO presence and securing rights to key cancer drug manufacturing.

UnitedHealth Board Reelects Directors, Hikes Dividend As CEO Pledges Review Of Medicare Practices

UnitedHealth raised its dividend and replaced its CEO amid scrutiny over Medicare billing and a nearly 40% stock decline this year.

Mounjaro Maker Eli Lilly Taps Swedish Firm Camurus To Target Long-Acting Obesity Market In $870-Million Deal

Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies targeting metabolic diseases.

FBI Arrests Chinese Researchers For Attempting To Smuggle 'Potential Agroterrorism Weapon' — Kash Patel Says One Expressed Loyalty To Chinese Communist Party

2 Chinese researchers arrested for sneaking a crop-killing fungus through Detroit airport, amid US-China tensions; FBI and CBP involved

Why Is Cancer Diagnostic Guardant Health Stock Trading Higher On Tuesday?

Guardant Health's Shield test receives FDA breakthrough status and NCCN guideline inclusion, with high accuracy shown in new ASCO and ECLIPSE study data.

Alto Neuroscience Adds 'Intriguing' Depression Asset Via Over $100 Million Deal

Alto Neuroscience acquires Chase's treatment-resistant depression drug portfolio for $1.75 million upfront; early data shows strong efficacy for lead candidate ALTO-207.

Jazz Pharma's Zepzelca Combo Shows Survival Edge In Lung Cancer Study

Jazz Pharma's Zepzelca plus Tecentriq significantly improved survival in a Phase 3 study for extensive-stage small-cell lung cancer patients.

Johnson & Johnson Highlights Multiple Blood Cancer Trial Data At ASCO Presentation

Johnson & Johnson shared positive ASCO 2025 results, including improved survival and remission in prostate and multiple myeloma patients.

Why ReShape Lifesciences Stock Is Soaring Today: Key Drivers Behind Weight-Loss Company's Surge

ReShape Lifesciences gains MDR and UKCA certification for all EU and UK devices, meeting strict regulatory standards well before the 2027 deadline.

Amazon Pharmacy Challenges CVS Health And Walgreens Dominance, Unveils New Features To Expand Medicare Access

Amazon Pharmacy introduces caregiver support and expands PillPack access for Medicare users, simplifying medication routines with secure tools and pre-sorted packets.

Merck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report

Merck reportedly offered over $3 billion for MoonLake Immunotherapeutics, targeting its late-stage inflammatory drug as it faces revenue pressure from Keytruda's looming patent cliff.

Barack Obama Accuses Republicans Of 'Trying To Weaken' Obamacare, Urges Voters To Call Their Senators As 'Millions Of People' Risk Losing Healthcare

Obama urges voters to call Senators to resist Republican efforts to weaken Affordable Care Act and put millions at risk of losing healthcare.